|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
����12 |
|
Ƥ��,��Ӧ�� |
| ��������������� | |
|
�ƺ��� |
|
���� |
|
���� |
| PubMed | |
|
Article by |
|
Article by |
|
Article by |
����12����Ӧ��Ƥ��
�ƺ���, ��ά��, ����
�ڶ���ҽ��ѧ����ҽԺƤ����, �Ϻ�200433
����12�������嶼����������ͬ�Ķ��������ɵ����������ӡ����Ǿ��ж��ֹ��ܡ������о���ʾ:����12��������֢��Ƥ�����ؼ���ϸ������,�����������������Ӧ��Ƥ����������һ����Ч������12����Ӧ��Ƥ���еĿ������ÿ�����ͨ���յ������ئ�,����Th1/Th2��ƽ�⼰����IgE�ȵIJ�����ʵ�ֵġ�
[2] Cassatella MA, Meda L, Gasperini S, et al. Interleukin-12 production by human polymorphonuclear leukocytes. Eur J Immunol, 1995,25(1):1-5.
[3] Hasko G, Szabo C. IL-12 as a therapeutic target for pharmacological modulation in immune-mediated and inflammatory diseases:regulation of T helper 1/T helper 2 responses. Br J Pharmacol, 1999, 127(6):1295-1304.
[4] Singh VK, Mehrotra S, Agarwal SS. The paradigm of Thl and Th2cytokines:its relevance to autoimmunity and allergy. Immunol Res,1999, 20(2):147-161.
[5] Leung DY. Atopic dermatitis:new insights and opportunities for therapeutic intervention. J Allergy Clin Immunol, 2000, 105 (5):860-876.
[6] Yawalkar N, Karlen S, Egli F, et al. Down-regulation of IL-12 by topical corticosteroids in chronic atopic dermatitis. J Allergy Clin Immuriol, 2000, 106(5):941-947.
[7] Borish L, Rosenwasser LJ. Update on cytokines. J Allergy Clin Immunol, 1996, 97(3):719-733.
[8] Hamid Q, Naseer T, Minshall EM, et al. In vivo expression of IL12 and IL-13 in atopic dermatitis. J Allergy Clin Immunol, 1996,98 (1):225-231.
[9] Shida K, Koizumi H, Shiratori I,et al. High serum levels of additional IL-18 forms may be reciprocally correlated with IgE levels in patients with atopic dermatitis, Immunol Lett, 2001, 79 (3):169-175.
[10] Habu Y, Seki S, Takayama E,et al. The mechanism of a defective IFN-gamma response to bacterial toxins in an atopic dermatitis model,NC/Nga mice, and the therapeutic effect of IFN-gamma, IL-12, or IL-18 on dermatitis. J Immunol, 2001, 166(9):5439-5447.
[11] Jung T, Witzak K, Dieckhoff K, et al. IFN-gamma is only partially restored by co-stimulation with IL-12, IL-2, IL-15, IL-18 or engagement of CD28. Clin Exp Allergy, 1999, 29 (2):207-216.
[12] Snijders A, Van der Pouw Kraan TC, Engel M, et al. Enhanced prostaglandin E2 production by monocytes in atopic dermatitis (AD) is not accompanied by enhanced production of IL-6, IL-10 or IL-12.Clin Exp Immunol, 1998, 111 (3):472-476.
[13] Lester MR, Hofer MF, Gately M, et al. Down-regulating effects of IL-4 and IL-10 on the IFN-gamma response in atopic dermatitis. J Immunol, 1995, 154 (11):6174-6181.
[14] Grewe M, Walther S, Gyufko K, et al. Analysis of the cytokine pattern expressed in situ in inhalant allergen patch test reactions of atopic dermatitis patients. J Invest Dermatol, 1995, 105 (3):407-410.
[15] Tada Y, Asahina A, Nakamura K, et al. Granulocyte/macrophage colony-stimulating factor inhibits IL-12 production of mouse Langerhans cells. J Immunol, 2000, 164(10):5113-5119.
[16] Teraki Y, Hotta T, Shiohara T, Increased circulating skin-homing cutaneous lymphocyte-associated antigen (CLA) + type 2 cytokine-producing cells, and decreased CLA + type 1 cytokine-producing cells in atopic dermatitis. Br J Dermatol, 2000, 143 (2):373-378.
[17] Kalinski P, Smits HH, Schuitemaker JH, et al. IL-4 is a mediator of IL-12p7C induction by human Th2 cells:reversal of polarized Th2phenotype by dendritic cells. J Immunol, 2000, 165 (4):1877-1881.
[18] Qureshi MH, Zhang T, Koguchi Y, et al. Combined effects of IL-12and IL-18 on the clinical course and local cytokine production in murine pulmonary infection with Cryptococcus neoformans. Eur J Immunol, 1999, 29(2):643-649.